×
0 0 0 0 0 0 0 -0.00273722627737237
Stockreport

Eagle Pharmaceuticals’ Vasopressin ANDA accepted for filing by the FDA [Seeking Alpha]

Endo Intl Plc (ENDP)  More Company Research Source: Seeking Alpha
Last endo intl plc earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.endo.com/newsroom/news-releases
PDF Eagle Pharmaceuticals’ Vasopressin ANDA accepted for filing by the FDAEagle Pharmaceuticals (NASDAQ:EGRX) hassubmitted and the FDA has accepted for filing its abbreviated new drug application (ANDA) for vasopressin injection, 1ml.This product is the generic version of Endo International's Vasostrict formulation, indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It had ~$400M in brand sales in 2017.Click to subscribe to real-time analytics on EGRXNow read:Valuation Dashboard: Healthcare - Update » [Read more]

IMPACT SNAPSHOT EVENT TIME: ENDP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ENDP alerts
from News Quantified
Opt-in for
ENDP alerts

from News Quantified
Opt-in for
ENDP alerts

from News Quantified